The clinical application and pharmacological mechanism of Bu-Zhong-Yi-Qi decoction for treating cancer-related fatigue: An overview
Authors:
Open Access
- 4 November 2022
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 156, 113969
Abstract
No abstract availableKeywords
Funding Information
- Shanghai University of Traditional Chinese Medicine (2020-54-18)
- Shanghai University of Traditional Chinese Medicine (2020-54-20)
This publication has 21 references indexed in Scilit:
- Ginsenoside Rb1 improves postoperative fatigue syndrome by reducing skeletal muscle oxidative stress through activation of the PI3K/Akt/Nrf2 pathway in aged ratsEuropean Journal of Pharmacology, 2014
- Quercetin Supplementation Attenuates the Progression of Cancer Cachexia in Apc MiceThe Journal of Nutrition, 2014
- Analysis of the restorative effect of Bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model using 1H-NMR-based metabonomicsJournal of Ethnopharmacology, 2014
- Patient Self-Reports of Symptoms and Clinician Ratings as Predictors of Overall Cancer SurvivalJNCI: Journal of the National Cancer Institute, 2011
- Polysaccharides from the root of Angelica sinensis promotes hematopoiesis and thrombopoiesis through the PI3K/AKT pathwayBMC Complementary and Alternative Medicine, 2010
- Bojungikki-Tang for Cancer-Related Fatigue: A Pilot Randomized Clinical TrialIntegrative Cancer Therapies, 2010
- STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effectBMC Medicine, 2009
- The course of severe fatigue in disease‐free breast cancer patients: a longitudinal studyPsycho-Oncology, 2006
- Fatigue in long‐term breast carcinoma survivorsCancer, 2006
- The Proton-Translocating NADH−Quinone Oxidoreductase in the Respiratory Chain: The Secret UnlockedBiochemistry, 2003